Characterization of microbial dysbiosis and metabolomic changes in dogs with acute diarrhea

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Guard, Blake C ^a   Barr, James W ^a   Reddivari, Lavanya ^b   Klemashevich, Cory ^c   Jayaraman, Arul ^c,d   Steiner, Jörg M ^a   Vanamala, Jairam ^b,e   Suchodolski, Jan S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c Department of Electrical and Computer Engineering   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e PENN STATE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 1H INDOLE; 5 METHOXY 1H INDOLE 3 CARBALDEHYDE; INDOLE DERIVATIVE; KYNURENIC ACID; PROPIONIC ACID; RNA 16S; SHORT CHAIN FATTY ACID; TRANSPOSASE; UNCLASSIFIED DRUG;

16S RRNA GENE; ACUTE DIARRHEA; ARTICLE; BACTEROIDETES; BLOODY DIARRHEA; CLOSTRIDIUM; CONTROLLED STUDY; DYSBIOSIS; FAECALIBACTERIUM; FECES MICROFLORA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; PYROSEQUENCING; RUMINOCOCCACEAE; SPECIES RICHNESS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; DIARRHEA; DOG; DOG DISEASE; FECES; METABOLOME; MICROBIOLOGY; MICROFLORA; VETERINARY;

BACTERIA (MICROORGANISMS); BACTEROIDETES; CANIS FAMILIARIS; CLOSTRIDIUM; FAECALIBACTERIUM;

ANIMALS; DIARRHEA; DOG DISEASES; DOGS; DYSBIOSIS; FECES; FEMALE; MALE; METABOLOME; METABOLOMICS; MICROBIOTA;

EID: 84930657053     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127259     Document Type: Article

References (62)

1. Frank DN, Zhu W, Sartor RB, Li E. Investigating the biological and clinical significance of human dysbioses. Trends in microbiology. 2011; 19(9):427-34. doi: 10.1016/j.tim.2011.06.005 PMID: 21775143; PubMed Central PMCID: PMC3164499.
2. Handl S, Dowd SE, Garcia-Mazcorro JF, Steiner JM, Suchodolski JS. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS microbiology ecology. 2011; 76(2):301-10. doi: 10.1111/j.1574-6941.2011.01058.x PMID: 21261668.
3. Suchodolski JS, Dowd SE, Westermarck E, Steiner JM, Wolcott RD, Spillmann T, et al. The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing. BMC microbiology. 2009; 9:210. doi: 10.1186/1471-2180-9-210 PMID: 19799792; PubMed Central PMCID: PMC2759960.
4. Zoetendal EG, Collier CT, Koike S, Mackie RI, Gaskins HR. Molecular ecological analysis of the gastrointestinal microbiota: a review. The Journal of nutrition. 2004; 134(2):465-72. PMID: 14747690.
5. Bell JA, Kopper JJ, Turnbull JA, Barbu NI, Murphy AJ, Mansfield LS. Ecological characterization of the colonic microbiota of normal and diarrheic dogs. Interdisciplinary perspectives on infectious diseases. 2008; 2008:149694. doi: 10.1155/2008/149694 PMID: 19282974; PubMed Central PMCID: PMC2648299.
6. Inness VL, McCartney AL, Khoo C, Gross KL, Gibson GR. Molecular characterisation of the gut microflora of healthy and inflammatory bowel disease cats using fluorescence in situ hybridisation with special reference to Desulfovibrio spp. Journal of animal physiology and animal nutrition. 2007; 91(1-2):48-53. doi: 10.1111/j.1439-0396.2006.00640.x PMID: 17217390.
7. Janeczko S, Atwater D, Bogel E, Greiter-Wilke A, Gerold A, Baumgart M, et al. The relationship of mucosal bacteria to duodenal histopathology, cytokine mRNA, and clinical disease activity in cats with inflammatory bowel disease. Veterinary microbiology. 2008; 128(1-2):178-93. doi: 10.1016/j.vetmic.2007.10.014 PMID: 18054447.
8. Suchodolski JS. Companion animals symposium: microbes and gastrointestinal health of dogs and cats. Journal of animal science. 2011; 89(5):1520-30. doi: 10.2527/jas.2010-3377 PMID: 21075970.
9. Suchodolski JS, Xenoulis PG, Paddock CG, Steiner JM, Jergens AE. Molecular analysis of the bacterial microbiota in duodenal biopsies from dogs with idiopathic inflammatory bowel disease. Veterinary microbiology. 2010; 142(3-4):394-400. doi: 10.1016/j.vetmic.2009.11.002 PMID: 19959301.
10. Xenoulis PG, Palculict B, Allenspach K, Steiner JM, Van House AM, Suchodolski JS. Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS microbiology ecology. 2008; 66(3):579-89. doi: 10.1111/j.1574-6941.2008.00556.x PMID: 18647355.
11. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature. 2008; 455(7216):1054-6. doi: 10.1038/4551054a PMID: 18948945.
12. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(10):3698-703. doi: 10.1073/pnas.0812874106 PMID: 19234110; PubMed Central PMCID: PMC2656143.
13. Rossi G, Pengo G, Caldin M, Palumbo Piccionello A, Steiner JM, Cohen ND, et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PloS one. 2014; 9(4):e94699. doi: 10.1371/journal.pone.0094699 PMID: 24722235; PubMed Central PMCID: PMC3983225.
14. Suchodolski JS, Markel ME, Garcia-Mazcorro JF, Unterer S, Heilmann RM, Dowd SE, et al. The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PloS one. 2012; 7 (12):e51907. doi: 10.1371/journal.pone.0051907 PMID: 23300577; PubMed Central PMCID: PMC3530590.
15. Foster ML, Dowd SE, Stephenson C, Steiner JM, Suchodolski JS. Characterization of the fungal microbiome (mycobiome) in fecal samples from dogs. Veterinary medicine international. 2013; 2013:658373. doi: 10.1155/2013/658373 PMID: 23738233; PubMed Central PMCID: PMC3655676.
16. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nature biotechnology. 2013; 31(9):814-21. doi: 10.1038/nbt.2676 PMID: 23975157; PubMed Central PMCID: PMC3819121.
17. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC microbiology. 2008; 8:43. doi: 10.1186/1471-2180-8-43 PMID: 18325110; PubMed Central PMCID: PMC2289825.
18. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods. 2010; 7(5):335-6. doi: 10.1038/nmeth.f.303 PMID: 20383131; PubMed Central PMCID: PMC3156573.
19. Garcia-Mazcorro JF, Suchodolski JS, Jones KR, Clark-Price SC, Dowd SE, Minamoto Y, et al. Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs. FEMS microbiology ecology. 2012; 80(3):624-36. doi: 10.1111/j.1574-6941.2012.01331.x PMID: 22324305.
20. Minamoto Y, Otoni CC, Steelman SM, Buyukleblebici O, Steiner JM, Jergens AE, et al. Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease. Gut microbes. 2014:1-15. Epub 2014/12/23. doi: 10.1080/19490976.2014.997612 PMID: 25531678.
21. Minamoto Y, Dhanani N, Markel ME, Steiner JM, Suchodolski JS. Prevalence of Clostridium perfringens, Clostridium perfringens enterotoxin and dysbiosis in fecal samples of dogs with diarrhea. Veterinary microbiology. 2014; 174(3-4):463-73. Epub 2014/12/03. doi: 10.1016/j.vetmic.2014.10.005 PMID: 25458422.
22. Moreau NM, Goupry SM, Antignac JP, Monteau FJ, Le Bizec BJ, Champ MM, et al. Simultaneous measurement of plasma concentrations and 13C-enrichment of short-chain fatty acids, lactic acid and ketone bodies by gas chromatography coupled to mass spectrometry. Journal of chromatography B, Analytical technologies in the biomedical and life sciences. 2003; 784(2):395-403. PMID: 12505787.
23. Zhu W, Stevens A, Dettmer K, Gottfried E, Hoves S, Kreutz M, et al. Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2011; 401(10):3249-61. doi: 10.1007/s00216-011-5436-y PMID: 21983980
24. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological). 1995:289-300.
25. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nature biotechnology. 2013. doi: 10.1038/nbt.2676 PMID: 23975157.
26. Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M, et al. Galaxy: a web-based genome analysis tool for experimentalists. Current protocols in molecular biology / edited by Frederick M Ausubel [et al]. 2010; Chapter 19:Unit 19 0 1-21. doi: 10.1002/0471142727.mb1910s89 PMID: 20069535.
27. Goecks J, Nekrutenko A, Taylor J, Galaxy T. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome biology. 2010; 11(8):R86. doi: 10.1186/gb-2010-11-8-r86 PMID: 20738864; PubMed Central PMCID: PMC2945788.
28. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Analytical chemistry. 2006; 78(3):779-87. doi: 10.1021/ac051437y PMID: 16448051.
29. Broeckling CD, Heuberger AL, Prince JA, Ingelsson E, Prenni JE. Assigning precursor-product ion relationships in indiscriminant MS/MS data from non-targeted metabolite profiling studies. Metabolomics. 2013; 9(1):33-43. doi: 10.1007/s11306-012-0426-4. WOS:000313736700005.
30. Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA, et al. Proposed minimum reporting standards for chemical analysis. Metabolomics. 2007; 3(3):211-21. doi: 10.1007/s11306-007-0082-2. WOS:000249945500006. PMID: 24039616
31. Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0 - a comprehensive server for metabolomic data analysis. Nucleic acids research. 2012; 40(Web Server issue):W127-33. doi: 10.1093/nar/gks374 PMID: 22553367; PubMed Central PMCID: PMC3394314.
32. Xia JG, Broadhurst DI, Wilson M, Wishart DS. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics. 2013; 9(2):280-99. doi: 10.1007/s11306-012-0482-9. WOS:000316913200003. PMID: 23543913
33. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(34):13780-5. doi: 10.1073/pnas.0706625104 PMID: 17699621; PubMed Central PMCID: PMC1959459.
34. Lynch SV, Goldfarb KC, Wild YK, Kong W, De Lisle RC, Brodie EL. Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota. Gut microbes. 2013; 4 (1):41-7. doi: 10.4161/gmic.22430 PMID: 23060053; PubMed Central PMCID: PMC3555885.
35. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiological reviews. 2001; 81(3):1031-64. PMID: 11427691.
36. Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. The Journal of nutrition. 2002; 132(5):1012-7. PMID: 11983830.
37. Cook SI, Sellin JH. Review article: short chain fatty acids in health and disease. Alimentary pharmacology & therapeutics. 1998; 12(6):499-507. PMID: 9678808.
38. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. Journal of clinical gastroenterology. 2006; 40(3):235-43. PMID: 16633129.
39. Antharam VC, Li EC, Ishmael A, Sharma A, Mai V, Rand KH, et al. Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea. Journal of clinical microbiology. 2013; 51(9):2884-92. doi: 10.1128/JCM.00845-13 PMID: 23804381; PubMed Central PMCID: PMC3754663.
40. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS microbiology letters. 2002; 217(2):133-9. PMID: 12480096.
41. Duncan SH, Hold GL, Harmsen HJ, Stewart CS, Flint HJ. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. International journal of systematic and evolutionary microbiology. 2002; 52(Pt 6):2141-6. PMID: 12508881.
42. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457(7228):480-4. doi: 10.1038/nature07540 PMID: 19043404; PubMed Central PMCID: PMC2677729.
43. Kondoh H, Ball CB, Adler J. Identification of a Methyl-Accepting Chemotaxis Protein for the Ribose and Galactose Chemoreceptors of Escherichia-Coli. Proceedings of the National Academy of Sciences of the United States of America. 1979; 76(1):260-4. doi: 10.1073/pnas.76.1.260. WOS: A1979GF88500057. PMID: 370826
44. Schott T, Kondadi PK, Hanninen ML, Rossi M. Comparative genomics of Helicobacter pylori and the human-derived Helicobacter bizzozeronii CIII-1 strain reveal the molecular basis of the zoonotic nature of non-pylori gastric Helicobacter infections in humans. BMC genomics. 2011; 12:534. doi: 10.1186/1471-2164-12-534 PMID: 22039924; PubMed Central PMCID: PMC3234257.
45. Benov L, Fridovich I. Escherichia coli exhibits negative chemotaxis in gradients of hydrogen peroxide, hypochlorite, and N-chlorotaurine: products of the respiratory burst of phagocytic cells. Proceedings of the National Academy of Sciences of the United States of America. 1996; 93(10):4999-5002. PMID: 8643518; PubMed Central PMCID: PMC39395.
46. Berg DE, Howe MM, Ajioka JW. Mobile DNA: American Society for Microbiology Washington, DC; 1989.
47. Aziz RK, Breitbart M, Edwards RA. Transposases are the most abundant, most ubiquitous genes in nature. Nucleic acids research. 2010; 38(13):4207-17. doi: 10.1093/Nar/Gkq140.WOS:000280538600009. PMID: 20215432
48. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006; 124(4):837-48. doi: 10.1016/j.cell.2006.02.017 PMID: 16497592.
49. Bansal T, Alaniz RC, Wood TK, Jayaraman A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107(1):228-33. doi: 10.1073/pnas.0906112107 PMID: 19966295; PubMed Central PMCID: PMC2806735.
50. Mogi C, Tobo M, Tomura H, Murata N, He XD, Sato K, et al. Involvement of proton-sensing TDAG8 in extracellular acidification-induced inhibition of proinflammatory cytokine production in peritoneal macrophages. Journal of immunology. 2009; 182(5):3243-51. doi: 10.4049/jimmunol.0803466 PMID: 19234222.
51. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011; 474(7351):307-17. doi: 10.1038/nature10209 PMID: 21677747; PubMed Central PMCID: PMC3204665.
52. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009; 461(7268):1282-6. doi: 10.1038/nature08530 PMID: 19865172; PubMed Central PMCID: PMC3256734.
53. Keszthelyi D, Troost FJ, Jonkers DM, Kruimel JW, Leue C, Masclee AA. Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: relation to serotonin and psychological state. Journal of psychosomatic research. 2013; 74(6):501-4. doi: 10.1016/j.jpsychores.2013.01.008 PMID: 23731747.
54. Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, Frederick R, et al. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109(7):2497-502. doi: 10.1073/pnas.1113873109 PMID: 22308364; PubMed Central PMCID: PMC3289319.
55. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448(7152):427-34. doi: 10.1038/nature06005 PMID: 17653185.
56. Abraham C, Cho JH. Inflammatory bowel disease. The New England journal of medicine. 2009; 361(21):2066-78. doi: 10.1056/NEJMra0804647 PMID: 19923578; PubMed Central PMCID: PMC3491806.
57. Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, Stenson WF, et al. Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflammatory bowel diseases. 2012; 18(7):1214-20. doi: 10.1002/ibd.21849 PMID: 21823214; PubMed Central PMCID: PMC3235239.
58. Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clinica chimica acta; international journal of clinical chemistry. 2006; 364(1-2):82-90. doi: 10.1016/j.cca.2005.06.013 PMID: 16139256.
59. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity. 2010; 18(1):190-5. doi: 10.1038/oby.2009.167 PMID: 19498350.
60. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-131. http://www.nature.com/nature/journal/v444/n7122/suppinfo/nature05414-S1.html. PMID: 17183312
61. Handl S, German AJ, Holden SL, Dowd SE, Steiner JM, Heilmann RM, et al. Faecal microbiota in lean and obese dogs2013 2013-05-01 00:00:00. 332-43 p. doi: 10.1111/1574-6941.12067 PMID: 23301868
62. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Science translational medicine. 2009; 1(6):6ra14. doi: 10.1126/scitranslmed.3000322 PMID: 20368178; PubMed Central PMCID: PMC2894525.